Similar articles

• Imipramine binding in depressed patients with psychogenic pain.

  Mellerup ET, Dam H, Kim MY, Loldrup D, Plenge P, Rosenberg R, Schepelern S. Mellerup ET, et al. Psychiatry Res. 1990 Apr;32(1):29-34. doi: 10.1016/0165-1781(90)90132-o. Psychiatry Res. 1990. PMID: 2161548
• Changes in platelet 3H-imipramine binding in depressed patients receiving electroconvulsive therapy.

  Maj M, Mastronardi P, Cerreta A, Romano M, Mazzarella B, Kemali D. Maj M, et al. Biol Psychiatry. 1988 Aug;24(4):469-72. doi: 10.1016/0006-3223(88)90188-6. Biol Psychiatry. 1988. PMID: 2841987 No abstract available.
• Why some depressed patients may have low platelet 3H-imipramine binding.

  Mellerup ET, Plenge P. Mellerup ET, et al. Acta Psychiatr Scand. 1990 Oct;82(4):330-4. doi: 10.1111/j.1600-0447.1990.tb01396.x. Acta Psychiatr Scand. 1990. PMID: 2175539
• Imipramine binding in depression and other psychiatric conditions.

  Mellerup ET, Plenge P. Mellerup ET, et al. Acta Psychiatr Scand Suppl. 1988;345:61-8. doi: 10.1111/j.1600-0447.1988.tb08569.x. Acta Psychiatr Scand Suppl. 1988. PMID: 2852451 Review.
• WHO pilot study on the validity of imipramine platelet receptor binding sites as a biological marker of endogenous depression. A preliminary report on the initial evaluation phase of a World Health Organization Collaborative Study.

  Bech P, Eplov L, Gastpar M, Gentsch C, Mendlewicz J, Plenge P, Rielaert C, Mellerup ET. Bech P, et al. Pharmacopsychiatry. 1988 May;21(3):147-50. doi: 10.1055/s-2007-1014667. Pharmacopsychiatry. 1988. PMID: 2841696 Review. No abstract available.